Was MPACT commercialised? Didn’t seem to offer a major improvement - although getting any survivors beyond months and into years is a positive but the population responder improvement seems quite material for AMP945 at this early stage. They may raise ahead of q3 and see if there’s lift off so they have hedged cash needs.
Was MPACT commercialised? Didn’t seem to offer a major...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.19M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 150000 | 6.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.6¢ | 150000 | 1 |
View Market Depth
| Last trade - 16.12pm 19/06/2024 (20 minute delay) ? |
| ATX (ASX) Chart |
Day chart unavailable